368 related articles for article (PubMed ID: 30268402)
1. Detecting 22q11.2 Deletion Syndrome in Newborns with Low T Cell Receptor Excision Circles from Severe Combined Immunodeficiency Screening.
Liao HC; Liao CH; Kao SM; Chiang CC; Chen YJ
J Pediatr; 2019 Jan; 204():219-224.e1. PubMed ID: 30268402
[TBL] [Abstract][Full Text] [Related]
2. High Incidence of Severe Combined Immunodeficiency Disease in Saudi Arabia Detected Through Combined T Cell Receptor Excision Circle and Next Generation Sequencing of Newborn Dried Blood Spots.
Al-Mousa H; Al-Dakheel G; Jabr A; Elbadaoui F; Abouelhoda M; Baig M; Monies D; Meyer B; Hawwari A; Dasouki M
Front Immunol; 2018; 9():782. PubMed ID: 29713328
[TBL] [Abstract][Full Text] [Related]
3. Identification of 22q11.2 Deletion Syndrome via Newborn Screening for Severe Combined Immunodeficiency.
Barry JC; Crowley TB; Jyonouchi S; Heimall J; Zackai EH; Sullivan KE; McDonald-McGinn DM
J Clin Immunol; 2017 Jul; 37(5):476-485. PubMed ID: 28540525
[TBL] [Abstract][Full Text] [Related]
4. Newborn Screening for Severe Primary Immunodeficiency Diseases in Sweden-a 2-Year Pilot TREC and KREC Screening Study.
Barbaro M; Ohlsson A; Borte S; Jonsson S; Zetterström RH; King J; Winiarski J; von Döbeln U; Hammarström L
J Clin Immunol; 2017 Jan; 37(1):51-60. PubMed ID: 27873105
[TBL] [Abstract][Full Text] [Related]
5. Newborn screening for severe combined immunodeficiency: Evaluation of a commercial T-cell receptor excision circle-based method in Victorian dried blood spots.
Richards S; Pitt J; Choo S
J Paediatr Child Health; 2018 Jan; 54(1):14-19. PubMed ID: 28861919
[TBL] [Abstract][Full Text] [Related]
6. A Droplet Digital PCR Method for Severe Combined Immunodeficiency Newborn Screening.
Vidal-Folch N; Milosevic D; Majumdar R; Gavrilov D; Matern D; Raymond K; Rinaldo P; Tortorelli S; Abraham RS; Oglesbee D
J Mol Diagn; 2017 Sep; 19(5):755-765. PubMed ID: 28826609
[TBL] [Abstract][Full Text] [Related]
7. Newborn screening for severe combined immunodeficiency using a novel and simplified method to measure T-cell excision circles (TREC).
Tagliaferri L; Kunz JB; Happich M; Esposito S; Bruckner T; Hübschmann D; Okun JG; Hoffmann GF; Schulz A; Kappe J; Speckmann C; Muckenthaler MU; Kulozik AE
Clin Immunol; 2017 Feb; 175():51-55. PubMed ID: 27916705
[TBL] [Abstract][Full Text] [Related]
8. Neonatal Levels of T-cell Receptor Excision Circles (TREC) in Patients with 22q11.2 Deletion Syndrome and Later Disease Features.
Gul KA; Øverland T; Osnes L; Baumbusch LO; Pettersen RD; Lima K; Abrahamsen TG
J Clin Immunol; 2015 May; 35(4):408-15. PubMed ID: 25814142
[TBL] [Abstract][Full Text] [Related]
9. Identification of 22q11.2 deletion syndrome via newborn screening for severe combined immunodeficiency. Two years' experience in Catalonia (Spain).
Martin-Nalda A; Cueto-González AM; Argudo-Ramírez A; Marin-Soria JL; Martinez-Gallo M; Colobran R; Plaja A; Castells N; Riviere J; Tizzano EF; Soler-Palacin P
Mol Genet Genomic Med; 2019 Dec; 7(12):e1016. PubMed ID: 31663686
[TBL] [Abstract][Full Text] [Related]
10. The TREC/KREC assay for the diagnosis and monitoring of patients with DiGeorge syndrome.
Froňková E; Klocperk A; Svatoň M; Nováková M; Kotrová M; Kayserová J; Kalina T; Keslová P; Votava F; Vinohradská H; Freiberger T; Mejstříková E; Trka J; Sedivá A
PLoS One; 2014; 9(12):e114514. PubMed ID: 25485546
[TBL] [Abstract][Full Text] [Related]
11. Newborn screening for severe T and B cell immunodeficiency in Israel: a pilot study.
Somech R; Lev A; Simon AJ; Korn D; Garty BZ; Amariglio N; Rechavi G; Almashanu S; Zlotogora J; Etzioni A
Isr Med Assoc J; 2013 Aug; 15(8):404-9. PubMed ID: 24079059
[TBL] [Abstract][Full Text] [Related]
12. An evaluation of the TREC assay with regard to the integration of SCID screening into the Dutch newborn screening program.
Blom M; Pico-Knijnenburg I; Sijne-van Veen M; Boelen A; Bredius RGM; van der Burg M; Schielen PCJI
Clin Immunol; 2017 Jul; 180():106-110. PubMed ID: 28487086
[TBL] [Abstract][Full Text] [Related]
13. Second-Tier Next Generation Sequencing Integrated in Nationwide Newborn Screening Provides Rapid Molecular Diagnostics of Severe Combined Immunodeficiency.
Strand J; Gul KA; Erichsen HC; Lundman E; Berge MC; Trømborg AK; Sørgjerd LK; Ytre-Arne M; Hogner S; Halsne R; Gaup HJ; Osnes LT; Kro GAB; Sorte HS; Mørkrid L; Rowe AD; Tangeraas T; Jørgensen JV; Alme C; Bjørndalen TEH; Rønnestad AE; Lang AM; Rootwelt T; Buechner J; Øverland T; Abrahamsen TG; Pettersen RD; Stray-Pedersen A
Front Immunol; 2020; 11():1417. PubMed ID: 32754152
[TBL] [Abstract][Full Text] [Related]
14. High-throughput multiplexed T-cell-receptor excision circle quantitative PCR assay with internal controls for detection of severe combined immunodeficiency in population-based newborn screening.
Gerstel-Thompson JL; Wilkey JF; Baptiste JC; Navas JS; Pai SY; Pass KA; Eaton RB; Comeau AM
Clin Chem; 2010 Sep; 56(9):1466-74. PubMed ID: 20660142
[TBL] [Abstract][Full Text] [Related]
15. Retrospective analysis of TREC based newborn screening results and clinical phenotypes in infants with the 22q11 deletion syndrome.
Lingman Framme J; Borte S; von Döbeln U; Hammarström L; Oskarsdóttir S
J Clin Immunol; 2014 May; 34(4):514-9. PubMed ID: 24610337
[TBL] [Abstract][Full Text] [Related]
16. TREC Based Newborn Screening for Severe Combined Immunodeficiency Disease: A Systematic Review.
van der Spek J; Groenwold RH; van der Burg M; van Montfrans JM
J Clin Immunol; 2015 May; 35(4):416-30. PubMed ID: 25893636
[TBL] [Abstract][Full Text] [Related]
17. Newborn blood spot screening test using multiplexed real-time PCR to simultaneously screen for spinal muscular atrophy and severe combined immunodeficiency.
Taylor JL; Lee FK; Yazdanpanah GK; Staropoli JF; Liu M; Carulli JP; Sun C; Dobrowolski SF; Hannon WH; Vogt RF
Clin Chem; 2015 Feb; 61(2):412-9. PubMed ID: 25502182
[TBL] [Abstract][Full Text] [Related]
18. Estimate of the contemporary live-birth prevalence of recurrent 22q11.2 deletions: a cross-sectional analysis from population-based newborn screening.
Blagojevic C; Heung T; Theriault M; Tomita-Mitchell A; Chakraborty P; Kernohan K; Bulman DE; Bassett AS
CMAJ Open; 2021; 9(3):E802-E809. PubMed ID: 34404688
[TBL] [Abstract][Full Text] [Related]
19. Newborn Screening for Severe T and B Cell Lymphopenia Using TREC/KREC Detection: A Large-Scale Pilot Study of 202,908 Newborns.
Marakhonov AV; Efimova IY; Mukhina AA; Zinchenko RA; Balinova NV; Rodina Y; Pershin D; Ryzhkova OP; Orlova AA; Zabnenkova VV; Cherevatova TB; Beskorovainaya TS; Shchagina OA; Polyakov AV; Markova ZG; Minzhenkova ME; Shilova NV; Larin SS; Khadzhieva MB; Dudina ES; Kalinina EV; Mudaeva DA; Saydaeva DH; Matulevich SA; Belyashova EY; Yakubovskiy GI; Tebieva IS; Gabisova YV; Irinina NA; Nurgalieva LR; Saifullina EV; Belyaeva TI; Romanova OS; Voronin SV; Shcherbina A; Kutsev SI
J Clin Immunol; 2024 Apr; 44(4):93. PubMed ID: 38578360
[TBL] [Abstract][Full Text] [Related]
20. Determining T and B Cell development by TREC/KREC analysis in primary immunodeficiency patients and healthy controls.
Şentürk G; Ng YY; Eltan SB; Başer D; Ogulur I; Altındirek D; Fırtına S; Yılmaz H; Kocamış B; Kıykım A; Camcıoğlu Y; Ar MC; Sudutan T; Beken S; Temel ŞG; Alanay Y; Karakoc-Aydiner E; Barış S; Özen A; Özbek U; Sayitoğlu M; Hatırnaz Ng Ö
Scand J Immunol; 2022 Mar; 95(3):e13130. PubMed ID: 34951041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
